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ABSTRACT
Objectives: To evaluate the frequency of peak
expiratory flow rate (PEFR) measurement and
clinical re-evaluation in the management of ED
asthmatic patients. Methods: This was a
retrospective chart review examining
consecutive asthma patients who presented to
the University of California Irvine ED between
September 1, 2003 and December 31, 2003.
Patients were excluded if they had a diagnosis of
COPD, lung cancer, pneumonia, congestive heart
failure, alpha 1 anti-trypsin deficiency or were
under 5 years of age. Data collected included
patient demographics, pulse oximetry reading(s),
ED treatments rendered, and frequencies of
PEFR measurement (pre and post therapy), of
clinical re-evaluations in the ED, and of ED return
visits. Results: Of the 122 ED visits from 111
patients, 11 (10%) patients returned during the
4 month study period, with 5 patients (4.5%)
returning in less than 72 hours. Seven (6.0%)
patients had PEFR done both pre and post
treatment and 24 (20%) had one or more PEFR
performed either before or after treatment. Only
61 (50%) of the visits had a documented clinical
re-evaluation prior to disposition. Conclusions:
Despite their documented role in asthma
treatment algorithms, PEFR was performed
infrequently and clinical re-evaluation was
documented in only half of cases. Recommended
algorithms for asthma management were not
commonly followed in this academic ED.
INTRODUCTION
Asthma exacerbation is a common chronic illness and
frequent reason for presentation to the Emergency
Department (ED).  In 2001 the National Health
Interview Survey found that 31.3 million respondents
were at one time given a diagnosis of asthma while 12
million respondents had suffered an asthma attack in
the previous year.1-2 The same survey showed 1.8
million visits to the ED in 2000, with a total of 4,487
asthma related deaths over the same 1 year period.1
To aid in asthma management, a series of algorithms
were created using pulmonary function testing as a
diagnostic adjunct to determine treatment course,
patient disposition, and outcome prediction.3-6 The
National Asthma Education and Prevention Program
(NAEPP) Expert Panel Report 2 proposed one such
algorithm which recommends use of objective values
of pulmonary function—peak expiratory flow rate
(PEFR) or forced expiratory volume in one second
(FEV1).
The importance of objectively measuring the degree
of airway obstruction during an acute asthma attack
is a recurring theme in the asthma literature. It has
been shown that patients’ subjective evaluation of
asthma severity and provider physical assessment of
the degree of airway obstruction are suboptimal in
determining actual impairment.7-10 Although FEV1 is
more sensitive for judging asthma severity, PEFR is
more readily available in many ED settings and
correlates well with spirometry.11-13 While the data
supporting the use of pulmonary function testing in
the ED is well established, emergency physicians (EP)
often make decisions regarding disposition and
treatment based solely on subjective complaint, repeatPage  59 The California Journal of Emergency Medicine VI:3, Jul-Sep, 2005
physical examination, or pulse oximetry.
Peak flow values are expressed as a percentage based
on the patients sex, height, and age. Patients may
know their prior best value which can serve as a new
baseline comparison for calculating a percentage of
best prior PEFR. A limiting factor in PEFR is patient
effort. It has been shown that children old enough to
follow directions should be
able to comply.
Although survey studies
have been undertaken to
assess NAEPP adherence,
there is no prior study
evaluating the frequency of PEFR testing in an ED
setting.14-16 Our goal is to evaluate how frequently
PEFR, repeat physical examination, subjective
complaint, and pulse oximetry are used to estimate
the degree of obstruction during an asthma
exacerbation.
METHODS
We conducted a retrospective chart review on
consecutive asthma patients (based on ICD-9 codes)
presenting to the University of California Irvine ED
from September 1, 2003 until December 31, 2003.
This study was classified as Institutional Review Board
exempt status. All patients under the age of 5 years
were arbitrarily excluded from the study due to
potential inability to accurately perform PEFR. If the
patient had an alternative diagnosis such as COPD,
lung cancer, pneumonia, congestive heart failure, alpha
1 antitrypsin deficiency, the chart was excluded. Once
identified, the charts were reviewed by a single non-
blinded reviewer. The patient’s sex, age, frequency
of repeat evaluations, PEFR pre and post treatment,
repeat pulse oximetry, and repeat visit rates were
recorded. Ages were reported as means + standard
deviations. All other statistics were descriptive.
RESULTS
We collected data from 122 consecutive visits for
asthma from 111 patients. There were relatively equal
numbers of males and females and the mean age was
27.8 + 16.4 years. Eleven (10%) patients returned
Table 2. Frequencies of PEFR or re-evaluation (n = 122).
Table 3. Treatments rendered.
Table 1. Demographics (n=111 patients).
during this 4 month period, with five (4.5%) returning
in less than 72 hours. See Table 1.
Only 7 (6%) patients had a documented PEFR both
pre and post treatment as proposed by the algorithms.
Only 24 (20%) had either a PEFR done prior to
treatment or subsequent to treatment. Overall, 61
(50%) of he visits had a documented re-evaluation
which was either subjective per the patient, or based
on physician physical examination. See Table 2.
All patients received albuterol, 81% of patients
received ipratropium, and 71% were given
corticosteroids.  One patient each was treated with
montelukast, epinephrine, and terbutaline respectively.
See Table 3.
None of the return visit patients had documented pre
and post treatment PEFR as suggested by various
algorithms. Only two of five patients had a single peak
flow done in the ED. Of the 5 who returned to the ED
in less than 72 hours, only 1 received steroids in the
ED. Two did not receive a prescription for steroids,Page 60 The California Journal of Emergency Medicine VI:3, Jul-Sep, 2005
and two of the three patients who received a
prescription lost it in less than 24 hours. See Table 4.
DISCUSSION
To our knowledge, there are no studies to date
evaluating the frequency of re-evaluation or PEFR in
the ED management of acute asthma exacerbation.
Despite the prominent role of pulmonary function tests
in various algorithms such as the NAEPP, in our
academic ED these recommendations from algorithms
were rarely followed. In our study, pre and post
treatment PEFR was recorded in only 6.0% of cases.
Additionally, PEFR was documented either pre or
post treatment in only 20% of cases. It has been shown
that subjective improvement and physical examination
are unreliable predictors of asthma severity.7-10
Nevertheless, in our ED repeat physical examination
was routinely used as the sole gauge of asthma severity.
In 40% of the cases there was no documented repeat
PEFR or repeat physical exam. Although this 40%
may represent a group with less severe asthma, a failure
to adhere to NAEPP guidelines could be interpreted
as not meeting the standard of ED care should a poor
outcome occur.17
Of the patients returning to the ED within 72 hours of
initial presentation, 4/5 (80%) had not received
steroids during the initial visit, and 2/5 (40%) had not
received a prescription for steroids. Previous studies
have shown relapse rates of greater than 25% when
patients were not treated with steroids.18 NAEPP
guidelines currently recommend a short course of
steroids for patients being discharged from the ED.4
Additionally, the literature supports early administration
of steroids to prevent both relapses and
hospitalizations.19-22 Despite the NAEPP
guidelines and numerous studies showing
the efficacy of steroids, these guidelines
were infrequently followed, offering
another area of potential for ED care
improvement.
LIMITATIONS
Because the study was a retrospective
chart review, it was difficult to determine
whether those cases lacking documentation
had in fact been the cases in which re-evaluation and
PEFR had not occurred. However, it is the authors’
observations that the majority of the cases lacking
documentation had in fact not undergone re-evaluation
or PEFR. Additionally, the results apply, whether the
issue is adherence to accepted asthma treatment
algorithms or inappropriate documentation of tests
performed.
Another potential for error lies in the manner in which
the charts were retrieved and in which the data was
extracted. We analyzed data from charts under the
ICD-9 code for asthma exacerbation and subsequent
treatment. Subsets of patients may have been missed
due to simple miscoding errors made any time before
the charts were stored.
Due to our small sample size (122 patients), the re-
visit rate of 11 patients was small and the re-visit rate
under 72 hours (5 patients) was even smaller. It is
pre-mature to draw many conclusions from this subset
of the population until larger populations can be
evaluated despite our similar rate of return-visit when
compared with other studies.23-25
Our study was also limited by the occasional difficulty
of obtaining a pre treatment PEFR. Nurses sometimes
initiated albuterol and ipratropium in the triage setting
making it impossible to obtain the pre treatment values.
This could potentially be improved by adopting a
nursing asthma protocol in triage. Additionally, patients
presenting in extremis are unlikely to undergo pre-
therapy PEFR and represent another subset of the
asthma population in which this adjunct is difficult to
evaluate.
Table 4. Treatments rendered to patients returning in
less than 72 hours.Page  61 The California Journal of Emergency Medicine VI:3, Jul-Sep, 2005
CONCLUSIONS
Despite numerous treatment algorithms and asthma
scores based on objective measures of pulmonary
function in acute asthma, in an academic ED setting
these algorithms were rarely followed. Over-reliance
on both physical exam and pulse oximetry, while
under-utilizing the objective measures such as PEFR
is counter to various asthma treatment guidelines such
as the NAEPP EPR-2. Attempts should be made to
increase the frequency of PEFR/FEV1 use as dictated
by the current standards of care in EM. Additionally,
early administration of steroids is a cornerstone of
asthma therapy and should be considered more
frequently in the ED to prevent relapse.
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